These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19352613)

  • 21. Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau disease.
    Albanyan S; Giles RH; Gimeno EM; Silver J; Murphy J; Faghfoury H; Morel CF; Machado J; Kim RH
    Eur J Med Genet; 2019 Mar; 62(3):177-181. PubMed ID: 30006056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Hippel Lindau syndrome.
    Kim JJ; Rini BI; Hansel DE
    Adv Exp Med Biol; 2010; 685():228-49. PubMed ID: 20687511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
    Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
    Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
    Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
    Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
    Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutations in the von Hippel-Lindau gene in Italian patients.
    Ciotti P; Garuti A; Gulli R; Ballestrero A; Bellone E; Mandich P
    Eur J Med Genet; 2009; 52(5):311-4. PubMed ID: 19464396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Von Hippel-Lindau syndrome - a case report].
    Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł
    Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.
    Gorospe M; Egan JM; Zbar B; Lerman M; Geil L; Kuzmin I; Holbrook NJ
    Mol Cell Biol; 1999 Feb; 19(2):1289-300. PubMed ID: 9891063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
    Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
    Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 33. Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.
    Berger MH; Kerr DA; Rangel Filho AE; Sargi ZB
    Head Neck; 2017 Mar; 39(3):E51-E54. PubMed ID: 28006088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
    Lee S; Neumann M; Stearman R; Stauber R; Pause A; Pavlakis GN; Klausner RD
    Mol Cell Biol; 1999 Feb; 19(2):1486-97. PubMed ID: 9891082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Hippel-Lindau disease.
    Kaelin WG
    Annu Rev Pathol; 2007; 2():145-73. PubMed ID: 18039096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.
    Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
    J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Von hippel-lindau disease: a genetic and clinical review.
    Haddad NM; Cavallerano JD; Silva PS
    Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene symbol: VHL.
    Mavrogiannis LA; Henderson A; Douglas F; Charlton RS
    Hum Genet; 2007 Apr; 121(2):299. PubMed ID: 17598225
    [No Abstract]   [Full Text] [Related]  

  • 40. [Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].
    Moch H
    Pathologe; 2008 Nov; 29 Suppl 2():149-52. PubMed ID: 18751708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.